Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$3.00+0.07 (+2.39%)
Close on Nov 11, 2026Market cap $126.37MP/E –Yield –
Apyx Medical operating margin
Operating margin is operating income as a percentage of revenue.
Apyx Medical's operating margin for the twelve months ending Sep 30, 2026 was -5.5%. For fiscal 2025 it was -12.2%, against -39.2% the year before. The highest annual figure on record is 3.8% in fiscal 2012.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -12.2% | +27.0 |
| FY2024 | Dec 31, 2024 | -39.2% | −6.2 |
| FY2023 | Dec 31, 2023 | -33.0% | +20.0 |
| FY2022 | Dec 31, 2022 | -52.9% | −23.2 |
| FY2021 | Dec 31, 2021 | -29.8% | +42.7 |
| FY2020 | Dec 31, 2020 | -72.5% | +1.4 |
| FY2019 | Dec 31, 2019 | -73.9% | +12.1 |
| FY2018 | Dec 31, 2018 | -86.0% | +49.7 |
| FY2017 | Dec 31, 2017 | -135.7% | −6.5 |
| FY2016 | Dec 31, 2016 | -129.2% | −105.5 |
| FY2015 | Dec 31, 2015 | -23.7% | −2.5 |
| FY2014 | Dec 31, 2014 | -21.1% | −5.6 |
| FY2013 | Dec 31, 2013 | -15.5% | −19.3 |
| FY2012 | Dec 31, 2012 | 3.8% | +3.9 |
| FY2011 | Dec 31, 2011 | -0.1% | +11.3 |
| FY2010 | Dec 31, 2010 | -11.4% | −14.0 |
| FY2009 | Dec 31, 2009 | 2.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -4.1% | +2.4 |
| Q2 FY2026 | Jun 30, 2026 | -13.0% | +9.6 |
| Q1 FY2026 | Mar 31, 2026 | -7.3% | +25.1 |
| Q4 FY2025 | Dec 31, 2025 | 0.1% | +21.5 |
| Q3 FY2025 | Sep 30, 2025 | -6.5% | +25.2 |
| Q2 FY2025 | Jun 30, 2025 | -22.6% | +23.0 |
| Q1 FY2025 | Mar 31, 2025 | -32.4% | +32.2 |
| Q4 FY2024 | Dec 31, 2024 | -21.4% | +18.0 |
| Q3 FY2024 | Sep 30, 2024 | -31.6% | +7.1 |
| Q2 FY2024 | Jun 30, 2024 | -45.7% | −36.6 |
| Q1 FY2024 | Mar 31, 2024 | -64.6% | −18.4 |
| Q4 FY2023 | Dec 31, 2023 | -39.4% | +7.7 |
| Q3 FY2023 | Sep 30, 2023 | -38.7% | +24.7 |
| Q2 FY2023 | Jun 30, 2023 | -9.1% | +49.0 |
| Q1 FY2023 | Mar 31, 2023 | -46.2% | +0.8 |
| Q4 FY2022 | Dec 31, 2022 | -47.0% | −37.0 |
| Q3 FY2022 | Sep 30, 2022 | -63.4% | −29.9 |
| Q2 FY2022 | Jun 30, 2022 | -58.1% | −22.0 |
| Q1 FY2022 | Mar 31, 2022 | -47.0% | +7.9 |
| Q4 FY2021 | Dec 31, 2021 | -10.1% | +7.9 |
| Q3 FY2021 | Sep 30, 2021 | -33.5% | +29.3 |
| Q2 FY2021 | Jun 30, 2021 | -36.0% | +107.5 |
| Q1 FY2021 | Mar 31, 2021 | -54.9% | +95.0 |
| Q4 FY2020 | Dec 31, 2020 | -17.9% | +53.2 |
| Q3 FY2020 | Sep 30, 2020 | -62.9% | −0.1 |
| Q2 FY2020 | Jun 30, 2020 | -143.6% | −77.0 |
| Q1 FY2020 | Mar 31, 2020 | -149.9% | −48.1 |
| Q4 FY2019 | Dec 31, 2019 | -71.1% | +28.7 |
| Q3 FY2019 | Sep 30, 2019 | -62.8% | +13.1 |
| Q2 FY2019 | Jun 30, 2019 | -66.5% | +13.0 |
| Q1 FY2019 | Mar 31, 2019 | -101.8% | −21.7 |
| Q4 FY2018 | Dec 31, 2018 | -99.8% | −11.3 |
| Q3 FY2018 | Sep 30, 2018 | -75.9% | +30.9 |
| Q2 FY2018 | Jun 30, 2018 | -79.5% | −23.0 |
| Q1 FY2018 | Mar 31, 2018 | -80.1% | +27.6 |
| Q4 FY2017 | Dec 31, 2017 | -88.5% | +2.6 |
| Q3 FY2017 | Sep 30, 2017 | -106.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -56.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -107.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -91.0% | – |
See a number that looks wrong?